US pharma giant buys Germany's Celesio in $8-bn deal

October 24, 2013

US pharmaceutical distributor McKesson on Thursday announced the purchase of German rival Celesio in a deal valued at more than $8 billion.

The combined company "will be one of the largest pharmaceutical wholesalers and providers of logistics and services in the worldwide," the German firm said in a statement.

The total transaction, including McKesson's takeover of Celesio's outstanding debt is valued at approximately $8.3 billion (6.3 billion euros, the statement added.

Both firms will keep their own separate brands.

The combined firm is expected to have annual revenue of more than $150 billion, employing some 81,500 people in 20 countries worldwide.

Earlier in the month, shares in McKesson rose sharply after the Wall Street Journal reported news of the buy-out.

Related Stories

Recommended for you

Re-framing the placebo effect and informed consent

October 29, 2015

(Medical Xpress)—Imagine that your doctor knows from evidence-based studies that if he tells you about certain, small side-effects to a particular drug, you are significantly more likely to experience that side effect than ...

Can exercise be replaced with a pill?

October 2, 2015

Everyone knows that exercise improves health, and ongoing research continues to uncover increasingly detailed information on its benefits for metabolism, circulation, and improved functioning of organs such as the heart, ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.